Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: a cross-sectional study of healthcare workers.
COVID-19
preventive medicine
public health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
06 01 2022
06 01 2022
Historique:
entrez:
7
1
2022
pubmed:
8
1
2022
medline:
12
1
2022
Statut:
epublish
Résumé
To examine the factors associated with COVID-19 vaccine receipt among healthcare workers and the role of vaccine confidence in decisions to vaccinate, and to better understand concerns related to COVID-19 vaccination. Cross-sectional anonymous survey among front-line, support service and administrative healthcare workers. Two large integrated healthcare systems (one private and one public) in New York City during the initial roll-out of the COVID-19 vaccine. 1933 healthcare workers, including nurses, physicians, allied health professionals, environmental services staff, researchers and administrative staff. The primary outcome was COVID-19 vaccine receipt during the initial roll-out of the vaccine among healthcare workers. Among 1933 healthcare workers who had been offered the vaccine, 81% had received the vaccine at the time of the survey. Receipt was lower among black (58%; OR: 0.14, 95% CI 0.1 to 0.2) compared with white (91%) healthcare workers, and higher among non-Hispanic (84%) compared with Hispanic (69%; OR: 2.37, 95% CI 1.8 to 3.1) healthcare workers. Among healthcare workers with concerns about COVID-19 vaccine safety, 65% received the vaccine. Among healthcare workers who agreed with the statement that the vaccine is important to protect family members, 86% were vaccinated. Of those who disagreed, 25% received the vaccine (p<0.001). In a multivariable analysis, concern about being experimented on (OR: 0.44, 95% CI 0.31 to 0.6), concern about COVID-19 vaccine safety (OR: 0.39, 95% CI 0.28 to 0.55), lack of influenza vaccine receipt (OR: 0.28, 95% CI 0.18 to 0.44), disagreeing that COVID-19 vaccination is important to protect others (OR: 0.37, 95% CI 0.27 to 0.52) and black race (OR: 0.38, 95% CI 0.24 to 0.59) were independently associated with COVID-19 vaccine non-receipt. Over 70% of all healthcare workers responded that they had been approached for vaccine advice multiple times by family, community members and patients. Our data demonstrated high overall receipt among healthcare workers. Even among healthcare workers with concerns about COVID-19 vaccine safety, side effects or being experimented on, over 50% received the vaccine. Attitudes around the importance of COVID-19 vaccination to protect others played a large role in healthcare workers' decisions to vaccinate. We observed striking inequities in COVID-19 vaccine receipt, particularly affecting black and Hispanic workers. Further research is urgently needed to address issues related to vaccine equity and uptake in the context of systemic racism and barriers to care. This is particularly important given the influence healthcare workers have in vaccine decision-making conversations in their communities.
Identifiants
pubmed: 34992113
pii: bmjopen-2021-053641
doi: 10.1136/bmjopen-2021-053641
pmc: PMC8739539
doi:
Substances chimiques
COVID-19 Vaccines
0
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e053641Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Ethn Health. 2021 Jan;26(1):80-93
pubmed: 33153287
Clin Pediatr (Phila). 2015 Apr;54(4):371-5
pubmed: 25238779
Am J Bioeth. 2021 Feb;21(2):11-18
pubmed: 33289442
PLoS Curr. 2015 Feb 25;7:
pubmed: 25789201
Soc Sci Med. 2019 Jan;221:87-94
pubmed: 30576982
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
Risk Anal. 2015 Jul;35(7):1210-29
pubmed: 25931009
Fam Community Health. 2021 Apr-Jun 01;44(2):110-111
pubmed: 33351518
Clin Infect Dis. 2022 Apr 9;74(7):1166-1173
pubmed: 34292319
PLoS One. 2020 Dec 9;15(12):e0243526
pubmed: 33296420
Nature. 2020 Jun;582(7811):230-233
pubmed: 32499650
Clin Infect Dis. 2021 Nov 16;73(10):1776-1783
pubmed: 33491049
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859
pubmed: 33301429
J Occup Environ Med. 2021 Oct 1;63(10):852-856
pubmed: 34138823
Am J Emerg Med. 2021 Oct;48:372-373
pubmed: 33573852
J Health Commun. 2020 Oct 2;25(10):819-826
pubmed: 33719874
Vaccine. 2016 Dec 20;34(52):6700-6706
pubmed: 27810314
J Community Health. 2021 Dec;46(6):1244-1251
pubmed: 33877534
PLoS Curr. 2015 Feb 25;7:
pubmed: 25789200
JAMA. 2020 Dec 29;:
pubmed: 33372943
Am J Infect Control. 2021 Feb;49(2):137-142
pubmed: 33227323
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
Am J Infect Control. 2021 Sep;49(9):1152-1157
pubmed: 33930516
Vaccine. 2012 Dec 17;31(1):213-8
pubmed: 23123019
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207
pubmed: 33196555
Pediatrics. 2020 Jul;146(1):
pubmed: 32540985
HEC Forum. 2021 Jun;33(1-2):143-154
pubmed: 33464452
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455
EClinicalMedicine. 2021 Feb;32:100713
pubmed: 33495751
Int J MCH AIDS. 2020;9(3):390-393
pubmed: 33014626
Hastings Cent Rep. 2020 May;50(3):58-60
pubmed: 32596896
Acad Emerg Med. 2021 Apr;28(4):455-458
pubmed: 33608937
MMWR Morb Mortal Wkly Rep. 2021 Feb 05;70(5):174-177
pubmed: 33539333